Key result
Nifedipine restores electrical activity and calcium transients in respiratory virus-infected cardiomyocytes.
Why the study?
Current diagnostic strategies for respiratory virus-induced myocarditis lack the temporal resolution and specificity to identify subtle early myocardial alterations and dynamic electrophysiological changes at high spatial resolution.
A novel multimodal biosensing platform successfully detected abnormal electrical and calcium transients in virus-infected cardiomyocytes, which were reversible with nifedipine, offering a tool for early myocarditis detection and drug screening.
Answers are grounded in this paper and cite their sources.
Should not yet alter clinical management of viral myocarditis; leaves open high-throughput biosensing for therapeutic screening in research.
Respiratory virus-induced myocarditis (RVIM) represents an escalating clinical challenge, attributed to rising incidence and widespread viral infections such as influenza and severe acute respiratory syndrome. This type of myocarditis is commonly associated with malignant arrhythmias and acute cardiac dysfunction, demanding the sensitive diagnostic tools to detect the functional abnormalities at their early stages. Current diagnostic strategies that rely on cardiac biomarkers and imaging modalities, often lack the temporal resolution and specificity to identify subtle myocardial alterations during the initial phases of disease. Moreover, these approaches are constrained to dynamically reflect the electrophysiological changes and fail to adequately resolve the intercellular differences at high spatial resolution. Herein, we present a multimodal biosensing platform that integrates microelectrode array (MEA) electrophysiology with calcium imaging. This platform enables simultaneous and dynamic monitoring of electrical activity and calcium transients in multiple cardiomyocytes at single-cell resolution. Using an in vitro model of respiratory virus-infected cardiomyocytes, we observed that exposure to SARS-CoV-2 or H1N1 pseudoviruses induced abnormal electrical activities and calcium transients, indicating the impaired excitation-contraction properties. Notably, respiratory virus-infected cardiomyocytes treated with the calcium channel blocker nifedipine effectively restore from the abnormal state. This multimodal biosensing system constitutes a robust preclinical platform to facilitate dynamic monitoring of arrhythmic activity and explore the respiratory virus-associated myocardial dysfunction at early stages. Furthermore, this multifuntional platform supports high-throughput therapeutic screening and quantitative evaluation of pharmacological responses, offering a technically versatile framework for translational investigation.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied Respiratory virus-induced myocarditis. Multimodal biosensing platform (MEA electrophysiology and calcium imaging) was evaluated on Electrical activity and calcium transients. A multimodal biosensing platform detected abnormal electrical activities and calcium transients in respiratory virus-infected cardiomyocytes, which were effectively restored by nifedipine treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: